Enterobacteriaceae Infections

"Enterobacteriaceae Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Infections with bacteria of the family ENTEROBACTERIACEAE.

Descriptor ID	D004756
MeSH Number(s)	C01.252.400.310
Concept/Terms	Enterobacteriaceae Infections Enterobacteriaceae Infections Enterobacterial Infections Infections, Enterobacterial Enterobacterial Infection Infection, Enterobacterial Infections, Enterobacteriaceae Enterobacteriaceae Infection Infection, Enterobacteriaceae Cronobacter Infections Cronobacter Infections Cronobacter Infection Infection, Cronobacter Infections, Cronobacter

Below are MeSH descriptors whose meaning is more general than "Enterobacteriaceae Infections".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Negative Bacterial Infections [C01.252.400]
Enterobacteriaceae Infections [C01.252.400.310]

Below are MeSH descriptors whose meaning is related to "Enterobacteriaceae Infections".

Below are MeSH descriptors whose meaning is more specific than "Enterobacteriaceae Infections".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Enterobacteriaceae Infections" by people in this website by year, and whether "Enterobacteriaceae Infections" was a major or minor topic of these publications.

Bar chart showing 32 publications over 16 distinct years, with a maximum of 9 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
2001	0	2	2
2005	1	0	1
2006	1	1	2
2007	1	0	1
2010	1	0	1
2011	1	0	1
2012	1	0	1
2013	0	1	1
2015	1	2	3
2016	3	0	3
2017	0	2	2
2018	5	4	9
2019	0	1	1
2020	0	1	1
2024	0	2	2

Below are the most recent publications written about "Enterobacteriaceae Infections" by people in Profiles.

Karlowsky JA, Wise MG, Hackel MA, Six DA, Uehara T, Daigle DM, Pevear DC, Moeck G, Sahm DF. Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22. J Antimicrob Chemother. 2024 12 02; 79(12):3116-3131.

View in: PubMed
Karlowsky JA, Lob SH, Hawser SP, Kothari N, Siddiqui F, Alekseeva I, DeRyke CA, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy-SMART 2017-2021. Eur J Clin Microbiol Infect Dis. 2024 Jul; 43(7):1343-1348.

View in: PubMed
Lob SH, Karlowsky JA, Young K, Motyl MR, Hawser S, Kothari ND, Sahm DF. In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017. J Med Microbiol. 2020 Feb; 69(2):207-217.

View in: PubMed
Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, Sahm DF. In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015. Antimicrob Agents Chemother. 2019 04; 63(4).

View in: PubMed
Kazmierczak KM, Bradford PA, Stone GG, de Jonge BLM, Sahm DF. In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015. Antimicrob Agents Chemother. 2018 12; 62(12).

View in: PubMed
Kazmierczak KM, de Jonge BLM, Stone GG, Sahm DF. In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012-15. J Antimicrob Chemother. 2018 10 01; 73(10):2782-2788.

View in: PubMed
Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A. Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1. Emerg Infect Dis. 2018 09; 24(9):1674-1682.

View in: PubMed
Cho H, Jaime H, de Oliveira RP, Kang B, Spolski R, Vaziri T, Myers TG, Thovarai V, Shen Z, Fox JG, Leonard WJ, Kelsall BL. Defective IgA response to atypical intestinal commensals in IL-21 receptor deficiency reshapes immune cell homeostasis and mucosal immunity. Mucosal Immunol. 2019 01; 12(1):85-96.

View in: PubMed
Vasagar B, Jain V, Germinario A, Watson HJ, Ouzts M, Presutti RJ, Alvarez S. Approach to Aquatic Skin Infections. Prim Care. 2018 Sep; 45(3):555-566.

View in: PubMed
Stainton SM, Abdelraouf K, Utley L, Pucci MJ, Lister T, Nicolau DP. Assessment of the In Vivo Activity of SPR741 in Combination with Azithromycin against Multidrug-Resistant Enterobacteriaceae Isolates in the Neutropenic Murine Thigh Infection Model. Antimicrob Agents Chemother. 2018 07; 62(7).

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement